Search Results
Search for other papers by Nicole Panarelli in
Google Scholar
PubMed
Search for other papers by Kathrin Tyryshkin in
Google Scholar
PubMed
Search for other papers by Justin Jong Mun Wong in
Google Scholar
PubMed
Search for other papers by Adrianna Majewski in
Google Scholar
PubMed
Search for other papers by Xiaojing Yang in
Google Scholar
PubMed
Search for other papers by Theresa Scognamiglio in
Google Scholar
PubMed
Search for other papers by Michelle Kang Kim in
Google Scholar
PubMed
Search for other papers by Kimberly Bogardus in
Google Scholar
PubMed
Search for other papers by Thomas Tuschl in
Google Scholar
PubMed
Search for other papers by Yao-Tseng Chen in
Google Scholar
PubMed
HHMI, Laboratory of RNA Molecular Biology, The Rockefeller University, New York, New York, USA
Search for other papers by Neil Renwick in
Google Scholar
PubMed
Introduction Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are increasingly common and clinically diverse neoplasms ( Yao et al . 2008 , Lawrence et al . 2011 ) that are challenging to evaluate histologically ( Klimstra 2016
University of Alabama at Birmingham, Department of Surgery, Division of Surgical Oncology, Birmingham, Alabama, USA
Search for other papers by Sarah B Bateni in
Google Scholar
PubMed
Susan Leslie Clinic for Neuroendocrine Tumors, Odette Cancer Centre - Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
Clinical evaluative sciences, Sunnybrook Research Institute, Toronto, Ontario, Canada
Search for other papers by Natalie G Coburn in
Google Scholar
PubMed
Susan Leslie Clinic for Neuroendocrine Tumors, Odette Cancer Centre - Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
Search for other papers by Calvin Law in
Google Scholar
PubMed
Susan Leslie Clinic for Neuroendocrine Tumors, Odette Cancer Centre - Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
Clinical evaluative sciences, Sunnybrook Research Institute, Toronto, Ontario, Canada
Search for other papers by Simron Singh in
Google Scholar
PubMed
Susan Leslie Clinic for Neuroendocrine Tumors, Odette Cancer Centre - Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
Clinical evaluative sciences, Sunnybrook Research Institute, Toronto, Ontario, Canada
Search for other papers by Sten Myrehaug in
Google Scholar
PubMed
Susan Leslie Clinic for Neuroendocrine Tumors, Odette Cancer Centre - Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
Clinical evaluative sciences, Sunnybrook Research Institute, Toronto, Ontario, Canada
Search for other papers by Angela Assal in
Google Scholar
PubMed
Susan Leslie Clinic for Neuroendocrine Tumors, Odette Cancer Centre - Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
Clinical evaluative sciences, Sunnybrook Research Institute, Toronto, Ontario, Canada
Search for other papers by Julie Hallet in
Google Scholar
PubMed
Introduction Neuroendocrine tumors (NETs) are rare tumors originating from the neuroendocrine system along the gastrointestinal tract and lungs ( Yao et al. 2008 , Hallet et al. 2015 , Dasari et al. 2017 , 2018 ). Although
Department of Molecular and Translational Medicine, Division of Biology and Genetics, University of Brescia, Brescia, Italy
Search for other papers by Chiara Alessandra Cella in
Google Scholar
PubMed
Metal Targeted Therapy & Immunology lab, Childrens’ cancer institute, Sydney, NSW, Australia
Search for other papers by Riccardo Cazzoli in
Google Scholar
PubMed
Search for other papers by Nicola Fazio in
Google Scholar
PubMed
Search for other papers by Giuseppina De Petro in
Google Scholar
PubMed
Search for other papers by Germano Gaudenzi in
Google Scholar
PubMed
Search for other papers by Silvia Carra in
Google Scholar
PubMed
Search for other papers by Mauro Romanenghi in
Google Scholar
PubMed
Search for other papers by Francesca Spada in
Google Scholar
PubMed
Search for other papers by Ilaria Grossi in
Google Scholar
PubMed
Search for other papers by Isabella Pallavicini in
Google Scholar
PubMed
Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy
Search for other papers by Saverio Minucci in
Google Scholar
PubMed
Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy
Search for other papers by Giovanni Vitale in
Google Scholar
PubMed
tumors (NETs), to be distinguished from neuroendocrine carcinomas (NECs) which are the poorly differentiated or high-grade forms. NETs have a variety of biological and clinical behaviors and are known to be highly vascularized. Accumulating knowledge
Department of Internal Medicine 2, University-Hospital, Klinikum der Universität München, Ludwig-Maximilians-University of Munich, Munich, Germany
Department of Internal Medicine 4, University-Hospital, Klinikum der Universität München, Ludwig-Maximilians-University of Munich, Munich, Germany
Search for other papers by Elke Tatjana Aristizabal Prada in
Google Scholar
PubMed
Department of Internal Medicine 2, University-Hospital, Klinikum der Universität München, Ludwig-Maximilians-University of Munich, Munich, Germany
Search for other papers by Vera Heinzle in
Google Scholar
PubMed
Institute of Pathology, Ludwig-Maximilians-University of Munich, Munich, Germany
Search for other papers by Thomas Knösel in
Google Scholar
PubMed
Department of Internal Medicine 2, University-Hospital, Klinikum der Universität München, Ludwig-Maximilians-University of Munich, Munich, Germany
Department of Internal Medicine 4, University-Hospital, Klinikum der Universität München, Ludwig-Maximilians-University of Munich, Munich, Germany
Search for other papers by Svenja Nölting in
Google Scholar
PubMed
Department of Internal Medicine 2, University-Hospital, Klinikum der Universität München, Ludwig-Maximilians-University of Munich, Munich, Germany
Department of Internal Medicine 4, University-Hospital, Klinikum der Universität München, Ludwig-Maximilians-University of Munich, Munich, Germany
Search for other papers by Gerald Spöttl in
Google Scholar
PubMed
Department of Internal Medicine 2, University-Hospital, Klinikum der Universität München, Ludwig-Maximilians-University of Munich, Munich, Germany
Department of Internal Medicine 4, University-Hospital, Klinikum der Universität München, Ludwig-Maximilians-University of Munich, Munich, Germany
Search for other papers by Julian Maurer in
Google Scholar
PubMed
Department of Internal Medicine 2, University-Hospital, Klinikum der Universität München, Ludwig-Maximilians-University of Munich, Munich, Germany
Department of Internal Medicine 4, University-Hospital, Klinikum der Universität München, Ludwig-Maximilians-University of Munich, Munich, Germany
Search for other papers by Christine Spitzweg in
Google Scholar
PubMed
Department of General, Visceral, Transplantation, Vascular and Thoracic Surgery, University-Hospital, Klinikum der Universität München, Ludwig-Maximilians-University of Munich, Munich, Germany
Search for other papers by Martin Angele in
Google Scholar
PubMed
Department of Internal Medicine 2, University-Hospital, Klinikum der Universität München, Ludwig-Maximilians-University of Munich, Munich, Germany
Department of Internal Medicine 4, University-Hospital, Klinikum der Universität München, Ludwig-Maximilians-University of Munich, Munich, Germany
Search for other papers by Nina Schmidt in
Google Scholar
PubMed
Klinik für Endokrinologie, Diabetologie und Klinische Ernährung, Universitätsspital Zürich, Zurich, Switzerland
Search for other papers by Felix Beuschlein in
Google Scholar
PubMed
Search for other papers by Günter K Stalla in
Google Scholar
PubMed
Search for other papers by Rainer Blaser in
Google Scholar
PubMed
Search for other papers by Klaus A Kuhn in
Google Scholar
PubMed
Department of Internal Medicine 2, University-Hospital, Klinikum der Universität München, Ludwig-Maximilians-University of Munich, Munich, Germany
Department of Internal Medicine 4, University-Hospital, Klinikum der Universität München, Ludwig-Maximilians-University of Munich, Munich, Germany
Search for other papers by Christoph J Auernhammer in
Google Scholar
PubMed
Introduction Neuroendocrine tumors (NETs) are highly heterogeneous tumors originating from distinct cell precursors ( Schimmack et al . 2011 ). Current data show an increase in incidence of gastroenteropancreatic neuroendocrine tumors (GEP
Search for other papers by Germano Gaudenzi in
Google Scholar
PubMed
Search for other papers by Silvia Carra in
Google Scholar
PubMed
Search for other papers by Alessandra Dicitore in
Google Scholar
PubMed
Search for other papers by Maria Celeste Cantone in
Google Scholar
PubMed
Department of Clinical Sciences and Community Health (DISCCO), University of Milan, Milan, Italy
Search for other papers by Luca Persani in
Google Scholar
PubMed
Department of Clinical Sciences and Community Health (DISCCO), University of Milan, Milan, Italy
Search for other papers by Giovanni Vitale in
Google Scholar
PubMed
Introduction Neuroendocrine tumors (NETs) represent a broad class of neoplasms originating from neuroendocrine cells. NETs can cause a wide array of symptoms depending on the type of tumor, its location and the production of several factors
Search for other papers by Jaydira Del Rivero in
Google Scholar
PubMed
Search for other papers by Josh Mailman in
Google Scholar
PubMed
Search for other papers by Michael W Rabow in
Google Scholar
PubMed
Search for other papers by Jennifer A Chan in
Google Scholar
PubMed
Search for other papers by Sarah Creed in
Google Scholar
PubMed
Search for other papers by Hagen F Kennecke in
Google Scholar
PubMed
Search for other papers by Janice Pasieka in
Google Scholar
PubMed
Search for other papers by Jennifer Zuar in
Google Scholar
PubMed
Search for other papers by Simron Singh in
Google Scholar
PubMed
Search for other papers by Lauren Fishbein in
Google Scholar
PubMed
lung cancer ( Temel et al. 2010 , Ferrell et al. 2017 ). Patients with neuroendocrine tumors (NETs) represent a unique population, as many have metastatic disease at presentation, yet can have prolonged survival rates for years. Since these
Search for other papers by Tobias Krauss in
Google Scholar
PubMed
Search for other papers by Alfonso Massimiliano Ferrara in
Google Scholar
PubMed
Search for other papers by Thera P Links in
Google Scholar
PubMed
Search for other papers by Ulrich Wellner in
Google Scholar
PubMed
Search for other papers by Irina Bancos in
Google Scholar
PubMed
Search for other papers by Andrey Kvachenyuk in
Google Scholar
PubMed
Search for other papers by Karina Villar Gómez de las Heras in
Google Scholar
PubMed
Search for other papers by Marina Y Yukina in
Google Scholar
PubMed
Search for other papers by Roman Petrov in
Google Scholar
PubMed
Search for other papers by Garrett Bullivant in
Google Scholar
PubMed
Search for other papers by Laura von Duecker in
Google Scholar
PubMed
Search for other papers by Swati Jadhav in
Google Scholar
PubMed
Search for other papers by Ursula Ploeckinger in
Google Scholar
PubMed
Search for other papers by Staffan Welin in
Google Scholar
PubMed
Search for other papers by Camilla Schalin-Jäntti in
Google Scholar
PubMed
Search for other papers by Oliver Gimm in
Google Scholar
PubMed
Search for other papers by Marija Pfeifer in
Google Scholar
PubMed
Search for other papers by Joanne Ngeow in
Google Scholar
PubMed
Search for other papers by Kornelia Hasse-Lazar in
Google Scholar
PubMed
Search for other papers by Gabriela Sansó in
Google Scholar
PubMed
Search for other papers by Xiaoping Qi in
Google Scholar
PubMed
Search for other papers by M Umit Ugurlu in
Google Scholar
PubMed
Search for other papers by Rene E Diaz in
Google Scholar
PubMed
Search for other papers by Nelson Wohllk in
Google Scholar
PubMed
Search for other papers by Mariola Peczkowska in
Google Scholar
PubMed
Search for other papers by Jens Aberle in
Google Scholar
PubMed
Search for other papers by Delmar M Lourenço Jr in
Google Scholar
PubMed
Search for other papers by Maria A A Pereira in
Google Scholar
PubMed
Search for other papers by Maria C B V Fragoso in
Google Scholar
PubMed
Search for other papers by Ana O Hoff in
Google Scholar
PubMed
Search for other papers by Madson Q Almeida in
Google Scholar
PubMed
Search for other papers by Alice H D Violante in
Google Scholar
PubMed
Search for other papers by Ana R P Quidute in
Google Scholar
PubMed
Search for other papers by Zhewei Zhang in
Google Scholar
PubMed
Search for other papers by Mònica Recasens in
Google Scholar
PubMed
Search for other papers by Luis Robles Díaz in
Google Scholar
PubMed
Search for other papers by Tada Kunavisarut in
Google Scholar
PubMed
Search for other papers by Taweesak Wannachalee in
Google Scholar
PubMed
Search for other papers by Sirinart Sirinvaravong in
Google Scholar
PubMed
Search for other papers by Eric Jonasch in
Google Scholar
PubMed
Search for other papers by Simona Grozinsky-Glasberg in
Google Scholar
PubMed
Search for other papers by Merav Fraenkel in
Google Scholar
PubMed
Search for other papers by Dmitry Beltsevich in
Google Scholar
PubMed
Search for other papers by Viacheslav I Egorov in
Google Scholar
PubMed
Search for other papers by Dirk Bausch in
Google Scholar
PubMed
Search for other papers by Matthias Schott in
Google Scholar
PubMed
Search for other papers by Nikolaus Tiling in
Google Scholar
PubMed
Search for other papers by Gianmaria Pennelli in
Google Scholar
PubMed
Search for other papers by Stefan Zschiedrich in
Google Scholar
PubMed
Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany
Search for other papers by Roland Därr in
Google Scholar
PubMed
Search for other papers by Juri Ruf in
Google Scholar
PubMed
Search for other papers by Timm Denecke in
Google Scholar
PubMed
Search for other papers by Karl-Heinrich Link in
Google Scholar
PubMed
Search for other papers by Stefania Zovato in
Google Scholar
PubMed
Search for other papers by Ernst von Dobschuetz in
Google Scholar
PubMed
Search for other papers by Svetlana Yaremchuk in
Google Scholar
PubMed
Search for other papers by Holger Amthauer in
Google Scholar
PubMed
Search for other papers by Özer Makay in
Google Scholar
PubMed
Search for other papers by Attila Patocs in
Google Scholar
PubMed
Search for other papers by Martin K Walz in
Google Scholar
PubMed
Search for other papers by Tobias B Huber in
Google Scholar
PubMed
Search for other papers by Jochen Seufert in
Google Scholar
PubMed
Search for other papers by Per Hellman in
Google Scholar
PubMed
Search for other papers by Raymond H Kim in
Google Scholar
PubMed
Search for other papers by Ekaterina Kuchinskaya in
Google Scholar
PubMed
Search for other papers by Francesca Schiavi in
Google Scholar
PubMed
Search for other papers by Angelica Malinoc in
Google Scholar
PubMed
Search for other papers by Nicole Reisch in
Google Scholar
PubMed
Search for other papers by Barbara Jarzab in
Google Scholar
PubMed
Search for other papers by Marta Barontini in
Google Scholar
PubMed
Search for other papers by Andrzej Januszewicz in
Google Scholar
PubMed
Search for other papers by Nalini Shah in
Google Scholar
PubMed
Search for other papers by William F Young Jr in
Google Scholar
PubMed
Search for other papers by Giuseppe Opocher in
Google Scholar
PubMed
Search for other papers by Charis Eng in
Google Scholar
PubMed
Search for other papers by Hartmut P H Neumann in
Google Scholar
PubMed
Search for other papers by Birke Bausch in
Google Scholar
PubMed
). Pancreatic neuroendocrine tumors (PanNETs) originate from the islets of the pancreas and may be hormonally active or inactive. PanNETs occur mainly as sporadic tumors, but 9% are also components of three hereditary syndromes, multiple endocrine neoplasia type
Search for other papers by Mojun Zhu in
Google Scholar
PubMed
Search for other papers by Karl R Sorenson in
Google Scholar
PubMed
Search for other papers by Rebecca Liu in
Google Scholar
PubMed
Search for other papers by Bonnie E Gould Rothberg in
Google Scholar
PubMed
Search for other papers by Thorvardur R Halfdanarson in
Google Scholar
PubMed
Introduction Pancreatic neuroendocrine tumors (PNETs) are a group of heterogeneous malignancies with diverse pathological findings and clinical behaviors. With an annual incidence that is less than 1 per 100,000 ( Halfdanarson et al. 2008
Aix-Marseille Université, Institut National de la Santé et de la Recherche Médicale (INSERM), U1251, Marseille Medical Genetics (MMG), Marseille, France
Department of Endocrinology, Assistance Publique – Hôpitaux de Marseille (AP-HM), Hôpital de la Conception, Centre de Référence des Maladies Rares Hypophysaires HYPO, Marseille, France
Search for other papers by Thomas Cuny in
Google Scholar
PubMed
Search for other papers by Wouter de Herder in
Google Scholar
PubMed
Department of Endocrinology, Assistance Publique – Hôpitaux de Marseille (AP-HM), Hôpital de la Conception, Centre de Référence des Maladies Rares Hypophysaires HYPO, Marseille, France
Search for other papers by Anne Barlier in
Google Scholar
PubMed
Search for other papers by Leo J Hofland in
Google Scholar
PubMed
Introduction Human gastroenteropancreatic neuroendocrine tumors (GEP-NETs) represent a heterogeneous group of tumors emerging from cells producing glycopeptides and biogenic amines ( Klöppel 2011 ). They account for approximately 0.5% of all
Search for other papers by Aristides Lytras in
Google Scholar
PubMed
Search for other papers by George Tolis in
Google Scholar
PubMed
Introduction Multiple neuroendocrine tumor syndromes may appear in a sporadic mode. The McCune–Albright syndrome (MAS; OMIM #174 800), a sporadic disease, representing a mosaic case of GNAS gene mutation leading to stimulatory G-protein α subunit (G